戴维医疗 (300314.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(戴维医疗)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 137,101,263.14110,495,493.89155,328,964.53159,336,608.47141,652,892.68159,445,978.47157,862,759.12
 营业收入(元) 137,101,263.14110,495,493.89155,328,964.53159,336,608.47141,652,892.68159,445,978.47157,862,759.12
二、营业总成本(元) 120,250,005.98106,518,946.41108,971,100.08128,388,450.38113,533,103.24118,679,195.92110,973,756.29
 营业成本(元) 63,052,222.3646,670,689.8864,421,182.5065,825,096.4262,887,192.0065,445,981.6364,319,864.25
 研发费用(元) 13,869,906.0614,723,892.6110,287,345.1120,610,358.4210,334,404.218,487,128.998,627,320.97
 营业税金及附加(元) 653,818.582,155,189.801,035,494.633,202,334.431,181,236.922,806,886.171,662,988.08
 销售费用(元) 25,787,836.5330,012,292.3222,670,944.0829,627,062.2828,422,572.2342,738,153.9721,132,671.77
 管理费用(元) 16,372,096.1516,240,364.7813,296,577.4412,186,906.8613,211,065.2413,344,174.6415,464,689.52
 财务费用(元) 514,126.30-3,283,482.98-2,740,443.68-3,063,308.03-2,503,367.36-14,143,129.48-233,778.30
  其中:利息费用(元) 111,116.58121,419.77132,751.17148,413.51138,065.89156,779.69155,548.33
  其中:利息收入(元) 1,750,472.632,951,250.972,802,839.843,974,656.563,506,625.854,070,728.392,988,975.65
 信用减值损失(元) -884,485.28-381,194.08-652,079.94662,985.93-524,663.95-137,196.95-473,723.97
三、其他经营收益
 加:投资收益(元) 2,258,224.48-577,437.60-2,554,623.67503,426.73886,980.463,341,996.546,596,225.75
  其中:对联营企业和合营企业的投资收益(元) 31,534.45-2,552,428.56-3,124,594.85-1,075,109.32-1,312,875.52782,124.644,754,526.15
 资产处置收益(元) 31,935.5116,316.94-43,673.5653,350.234,487.86-287,493.261,539.60
 其他收益(元) 759,550.325,376,469.611,381,449.452,456,649.276,653,674.812,461,598.674,867,363.37
四、营业利润(元) 19,016,482.198,410,702.3544,488,936.7332,198,296.2135,140,268.6246,145,687.5557,880,407.58
 加:营业外收入(元) 118,776.30-3,997.2582,130.68113,515.4817,538.8515,087.489,408.41
 减:营业外支出(元) 46,870.3939,174.92140,875.845,103,113.3141,372.4457,109.9493,889.72
五、利润总额(元) 19,088,388.108,367,530.1844,430,191.5727,208,698.3835,116,435.0346,103,665.0957,795,926.27
 减:所得税费用(元) 2,306,661.40-51,386.426,322,962.812,393,097.924,097,923.184,346,153.387,776,638.78
六、净利润(元) 16,781,726.708,418,916.6038,107,228.7624,815,600.4631,018,511.8541,757,511.7150,019,287.49
(一)按经营持续性分类
  持续经营净利润(元) 16,781,726.708,418,916.6038,107,228.7624,815,600.4631,018,511.8541,757,511.7150,019,287.49
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 16,781,726.708,418,916.6038,107,228.7624,815,600.4631,018,511.8541,757,511.7150,019,287.49
 扣除非经常性损益后的净利润(元) 14,463,928.454,784,188.1739,443,757.8922,822,605.3323,543,541.3737,769,350.0944,387,084.42
七、每股收益
 一、基本每股收益(元) 0.060.030.130.080.110.150.17
 二、稀释每股收益(元) 0.060.030.130.080.110.150.17
八、其他综合收益(元) 478,591.81------
 归属于母公司股东的其他综合收益(元) 478,591.81------
九、综合收益总额(元) 17,260,318.518,247,115.1538,107,228.7624,815,600.4631,018,511.8541,757,511.7150,019,287.49
 归属于母公司所有者的综合收益总额(元) 17,260,318.518,247,115.1538,107,228.7624,815,600.4631,018,511.8541,757,511.7150,019,287.49
公告日期 2024-10-232024-08-202024-04-202024-04-092023-10-252023-08-222023-04-21
审计意见(境内) 标准无保留意见

前瞻产业研究院